These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19661119)

  • 21. J-curve relationship between long term glycemic control and mortality in diabetic patients with acute myocardial infarction undergoing percutaneous coronary intervention.
    Choi IJ; Choo EH; Kim HJ; Lim S; Moon D; Lee KY; Hwang BH; Kim CJ; Park MW; Lee JM; Park CS; Kim HY; Yoo KD; Jeon DS; Chung WS; Kim MC; Jeong MH; Ahn Y; Chang K
    Cardiovasc Diabetol; 2021 Dec; 20(1):234. PubMed ID: 34911555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Troponin T is a better predictor than creatine kinase-MB of long-term mortality after coronary artery bypass graft surgery.
    Søraas CL; Friis C; Engebretsen KV; Sandvik L; Kjeldsen SE; Tønnessen T
    Am Heart J; 2012 Nov; 164(5):779-85. PubMed ID: 23137510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relation of Post-Coronary Artery Bypass Graft Creatine Kinase-MB Elevations and New Q Waves With Long-Term Cardiovascular Death in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease.
    Domanski M; Farkouh ME; Zak V; French J; Alexander JH; Bochenek A; Hamon M; Mahaffey K; Puskas J; Smith P; Shrader P; Fuster V
    Am J Cardiol; 2016 Dec; 118(11):1655-1660. PubMed ID: 27816118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of type 2 diabetes mellitus on short- and long-term mortality after coronary artery bypass surgery.
    Kogan A; Ram E; Levin S; Fisman EZ; Tenenbaum A; Raanani E; Sternik L
    Cardiovasc Diabetol; 2018 Nov; 17(1):151. PubMed ID: 30497472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intensity of Glycemic Control Affects Long-Term Survival After Coronary Artery Bypass Graft Surgery.
    Robich MP; Iribarne A; Leavitt BJ; Malenka DJ; Quinn RD; Olmstead EM; Ross CS; Sawyer DB; Klemperer JD; Clough RA; Kramer RS; Baribeau YR; Sardella GL; DiScipio AW;
    Ann Thorac Surg; 2019 Feb; 107(2):477-484. PubMed ID: 30273572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short-term outcomes following coronary artery bypass graft surgery in insulin treated and non-insulin treated diabetes: A tertiary hospital experience in Australia.
    Lan NSR; Ali U; Fegan PG; Larbalestier R; Hitchen SA; Hort A; Yeap BB
    Diabetes Metab Syndr; 2020; 14(4):455-458. PubMed ID: 32371190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Revascularization Trends in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease Presenting With Non-ST Elevation Myocardial Infarction: Insights From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get with the Guidelines (NCDR ACTION Registry-GWTG).
    Pandey A; McGuire DK; de Lemos JA; Das SR; Berry JD; Brilakis ES; Banerjee S; Marso SP; Barsness GW; Simon DN; Roe M; Goyal A; Kosiborod M; Amsterdam EA; Kumbhani DJ
    Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):197-205. PubMed ID: 27166210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elective percutaneous coronary intervention: the relationship between preprocedural blood glucose levels and periprocedural myocardial injury.
    Madani M; Alizadeh K; Ghazaee SP; Zavarehee A; Abdi S; Shakerian F; Salehi N; Firouzi A
    Tex Heart Inst J; 2013; 40(4):410-7. PubMed ID: 24082370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac troponin I versus creatine kinase-MB in the detection of postoperative cardiac events after coronary artery bypass grafting surgery.
    Tzimas PG; Milionis HJ; Arnaoutoglou HM; Kalantzi KJ; Pappas K; Karfis E; Korantzopoulos P; Drossos G; Papadopoulos GS
    J Cardiovasc Surg (Torino); 2008 Feb; 49(1):95-101. PubMed ID: 18212694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accuracy of Myocardial Biomarkers in the Diagnosis of Myocardial Infarction After Revascularization as Assessed by Cardiac Resonance: The Medicine, Angioplasty, Surgery Study V (MASS-V) Trial.
    Hueb W; Gersh BJ; Alves da Costa LM; Costa Oikawa FT; Vieira de Melo RM; Rezende PC; Garzillo CL; Lima EG; Nomura CH; Villa AV; Hueb AC; Cassaro Strunz CM; Favarato D; Takiuti ME; de Albuquerque CP; Ribeiro da Silva EE; Franchini Ramires JA; Kalil Filho R
    Ann Thorac Surg; 2016 Jun; 101(6):2202-8. PubMed ID: 26912303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective effect of pyridoxal-5-phosphate (MC-1) on perioperative myocardial infarction is independent of aortic cross clamp time: results from the MEND-CABG trial.
    Carrier M; Emery R; Kandzari DE; Harrington R; Guertin MC; Tardif JC
    J Cardiovasc Surg (Torino); 2008 Apr; 49(2):249-53. PubMed ID: 18431346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypotheses, rationale, design, and methods for prognostic evaluation of cardiac biomarker elevation after percutaneous and surgical revascularization in the absence of manifest myocardial infarction. A comparative analysis of biomarkers and cardiac magnetic resonance. The MASS-V Trial.
    Hueb W; Gersh BJ; Rezende PC; Garzillo CL; Lima EG; Vieira RD; Garcia RM; Favarato D; Segre CA; Pereira AC; Soares PR; Ribeiro E; Lemos P; Perin MA; Strunz CC; Dallan LA; Jatene FB; Stolf NA; Hueb AC; Dias R; Gaiotto FA; da Costa LM; Oikawa FT; de Melo RM; Serrano CV; de Ávila LF; Villa AV; Filho JR; Nomura C; Ramires JA; Kalil Filho R;
    BMC Cardiovasc Disord; 2012 Aug; 12():65. PubMed ID: 22898311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stenting.
    Kassaian SE; Goodarzynejad H; Boroumand MA; Salarifar M; Masoudkabir F; Mohajeri-Tehrani MR; Pourhoseini H; Sadeghian S; Ramezanpour N; Alidoosti M; Hakki E; Saadat S; Nematipour E
    Cardiovasc Diabetol; 2012 Jul; 11():82. PubMed ID: 22805289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence and Potential Mechanism(s) of Post-Procedural Rise of Cardiac Biomarker in Patients With Coronary Artery Narrowing After Implantation of an Everolimus-Eluting Bioresorbable Vascular Scaffold or Everolimus-Eluting Metallic Stent.
    Ishibashi Y; Muramatsu T; Nakatani S; Sotomi Y; Suwannasom P; Grundeken MJ; Cho YK; Garcia-Garcia HM; van Boven AJ; Piek JJ; Sabaté M; Helqvist S; Baumbach A; McClean D; de Sousa Almeida M; Wasungu L; Miquel-Hebert K; Dudek D; Chevalier B; Onuma Y; Serruys PW
    JACC Cardiovasc Interv; 2015 Jul; 8(8):1053-1063. PubMed ID: 26205444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HbA1c and diabetes predict perioperative hyperglycemia and glycemic variability in on-pump coronary artery bypass graft patients.
    Masla M; Gottschalk A; Durieux ME; Groves DS
    J Cardiothorac Vasc Anesth; 2011 Oct; 25(5):799-803. PubMed ID: 21111636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Point-of-care assessment of platelet reactivity after clopidogrel to predict myonecrosis in patients undergoing percutaneous coronary intervention.
    Mangiacapra F; Barbato E; Patti G; Gatto L; Vizzi V; Ricottini E; D'Ambrosio A; Wijns W; Di Sciascio G
    JACC Cardiovasc Interv; 2010 Mar; 3(3):318-23. PubMed ID: 20298992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased mortality after coronary artery bypass graft surgery is associated with increased levels of postoperative creatine kinase-myocardial band isoenzyme release: results from the GUARDIAN trial.
    Klatte K; Chaitman BR; Theroux P; Gavard JA; Stocke K; Boyce S; Bartels C; Keller B; Jessel A;
    J Am Coll Cardiol; 2001 Oct; 38(4):1070-7. PubMed ID: 11583884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of pexelizumab in coronary artery bypass graft surgery with extended aortic cross-clamp time.
    Smith PK; Carrier M; Chen JC; Haverich A; Levy JH; Menasché P; Shernan SK; Van de Werf F; Adams PX; Todaro TG; Verrier E
    Ann Thorac Surg; 2006 Sep; 82(3):781-8; discussion 788-9. PubMed ID: 16928483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of large periprocedural myocardial infarction on mortality after percutaneous coronary intervention and coronary artery bypass grafting for left main disease: an analysis from the EXCEL trial.
    Ben-Yehuda O; Chen S; Redfors B; McAndrew T; Crowley A; Kosmidou I; Kandzari DE; Puskas JD; Morice MC; Taggart DP; Leon MB; Lembo NJ; Brown WM; Simonton CA; Dressler O; Kappetein AP; Sabik JF; Serruys PW; Stone GW
    Eur Heart J; 2019 Jun; 40(24):1930-1941. PubMed ID: 30919909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diabetes is not a risk factor for hospital mortality following contemporary coronary artery bypass grafting.
    Filsoufi F; Rahmanian PB; Castillo JG; Mechanick JI; Sharma SK; Adams DH
    Interact Cardiovasc Thorac Surg; 2007 Dec; 6(6):753-8. PubMed ID: 17901106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.